Browsing by Author CHEN YU ZONG

Select a letter below to browse by last name or type
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Showing results 59 to 78 of 183 < previous   next >
Issue DateTitleAuthor(s)
17-Aug-2007Efficacy of different protein descriptors in predicting protein functional familiesOng, S.A.K.; Lin, H.H.; Chen, Y.Z. ; Li, Z.R.; Cao, Z.
1-Apr-2004Enzyme Family Classification by Support Vector MachinesCai, C.Z. ; Han, L.Y. ; Ji, Z.L. ; Chen, Y.Z. 
Jun-2008Evaluation of virtual screening performance of support vector machines trained by sparsely distributed active compoundsMa, X.H. ; Wang, R.; Yang, S.Y.; Li, Z.R.; Xue, Y.; Wei, Y.C.; Low, B.C. ; Chen, Y.Z. 
Apr-2011Exploration of (S)-3-aminopyrrolidine as a potentially interesting scaffold for discovery of novel Abl and PI3K dual inhibitorsZhang, C.; Tan, C.; Zu, X.; Zhai, X.; Liu, F.; Chu, B.; Ma, X. ; Chen, Y. ; Gong, P.; Jiang, Y.
1-Feb-2013Exploration of 1-(3-chloro-4-(4-oxo-4H-chromen-2-yl)phenyl)-3-phenylurea derivatives as selective dual inhibitors of Raf1 and JNK1 kinases for anti-tumor treatmentJin, F.; Gao, D.; Zhang, C.; Liu, F.; Chu, B.; Chen, Y.; Chen, Y.Z. ; Tan, C.; Jiang, Y.
15-Sep-2013Exploration of N-(2-aminoethyl)piperidine-4-carboxamide as a potential scaffold for development of VEGFR-2, ERK-2 and Abl-1 multikinase inhibitorJin, F.; Gao, D.; Wu, Q.; Liu, F.; Chen, Y. ; Tan, C.; Jiang, Y.
31-Jul-2007Formulation development of transdermal dosage forms: Quantitative structure-activity relationship model for predicting activities of terpenes that enhance drug penetration through human skinKang, L. ; Yap, C.W. ; Lim, P.F.C. ; Chen, Y.Z. ; Ho, P.C. ; Chan, Y.W.; Wong, G.P.; Chan, S.Y. 
May-2007Functional annotation of ORFs in viral genomes from primary sequence by support vector machine approachLiang, L.; Han, L.-Y. ; Cai, C. ; Huang, W.; Chen, Y. ; Ji, Z.
Jan-2011HIT: Linking herbal active ingredients to targetsYe, H.; Ye, L.; Kang, H.; Zhang, D.; Tao, L.; Tang, K.; Liu, X.; Zhu, R.; Liu, Q.; Chen, Y.Z. ; Li, Y.; Cao, Z.
2008Homology-free prediction of functional class of proteins and peptides by support vector machinesZhu, F. ; Han, L.Y. ; Chen, X.; Lin, H.H.; Ong, S.; Xie, B.; Zhang, H.L.; Chen, Y.Z. 
2001Hydrogen-bond disruption probability in proteins by a modified self-consistent harmonic approachCao, Z.W. ; Chen, Y.Z. 
Mar-2010Identification of small molecule aggregators from large compound libraries by support vector machinesRao, H.; Li, Z.; Li, X.; Ma, X. ; Ung, C. ; Li, H. ; Liu, X.; Chen, Y. 
17-May-2010Identifying novel type ZBGs and nonhydroxamate HDAC inhibitors through a SVM based virtual screening approachLiu, X.H.; Song, H.Y.; Zhang, J.X.; Han, B.C.; Wei, X.N.; Ma, X.H. ; Cui, W.K.; Chen, Y.Z. 
30-Apr-2010In silico prediction and screening of γ-secretase inhibitors by molecular descriptors and machine learning methodsYang, X.-G.; Wei, L.V.; Chen, Y.U.-Z. ; Ying, X.U.E.
2012In silico prediction of adverse drug reactions and toxicities based on structural, biological and clinical dataLiu, X.; Shi, Z.; Xue, Y.; Li, Z.R.; Yang, S.Y.; Wei, Y.Q.; Chen, Y.Z. 
2007In silico prediction of pregnane X receptor activators by machine learning approachesUng, C.Y. ; Li, H. ; Yap, C.W. ; Chen, Y.Z. 
1-May-2013In silico prediction of spleen tyrosine kinase inhibitors using machine learning approaches and an optimized molecular descriptor subset generated by recursive feature elimination methodLi, B.-K.; Cong, Y.; Yang, X.-G.; Xue, Y.; Chen, Y.-Z. 
1-Jul-2006In silico search of putative adverse drug reaction related proteins as a potential tool for facilitating drug adverse effect predictionJi, Z.L.; Wang, Y.; Yu, L.; Han, L.Y. ; Zheng, C.J. ; Chen, Y.Z. 
May-2010In-silico approaches to multi-target drug discovery computer aided multi-target drug design, multi-target virtual screeningMa, X.H. ; Shi, Z.; Tan, C.; Jiang, Y.; Go, M.L. ; Low, B.C. ; Chen, Y.Z. 
Apr-2006Increasing the odds of drug hit identification by screening against receptor homologs?Ji, Z.L. ; Li, Z.R. ; Wang, J.F.; Cai, C.Z. ; Han, L.Y. ; Zheng, C.J. ; Chen, Y.Z.